Gamitrinib TPP,1131626-46-4

价格询价

品牌MedChemExpress(MCE)
产地美国
货号
HY-102007
更新日期2025年12月05日

MedChemExpress LLC

品牌商

14 年钻石会员

Gamitrinib TPP

CAS No. : 1131626-46-4

MCE 国际站：Gamitrinib TPP

产品活性：Gamitrinib TPP 是一种 Gamitrinib (GA) 线粒体基质的抑制剂。Gamitrinib TPP 是一种靶向线粒体的 HSP90 抑制剂。具有抗癌活性。

研究领域：Cell Cycle/DNA Damage | Metabolic Enzyme/Protease

作用靶点：HSP

In Vitro: Within a 16-hour exposure, concentrations of Gamitrinib TPP of 15-20 μM indistinguishably kill patient-derived and cultured glioblastoma cell lines. This cell death response has the hallmarks of mitochondrial apoptosis, with loss of organelle inner membrane potential, release of cytochrome c in the cytosol, activation of initiator caspase-9 and effector caspase-3 and -7, and cellular reactivity for annexin V. Because Hsp90s are selectively present in mitochondria of tumor cells, but not normal tissues, Gamitrinib TPP does not kill normal fetal human astrocytes (FHAS). Under comparable conditions, nonsubcellularly targeted 17-AAG has no effect on normal or tumor cells.

In Vivo: Interestingly, 2 cycles of intracranial TRAIL combined with systemic G-TPP suppress the growth of established glioblastomas, with no significant animal weight loss throughout treatment. Analysis of brain sections from these mice, but not single agent-treated animals, show loss of tumor cell proliferation, internucleosomal DNA fragmentation, and caspase-3 activity, consistent with extensive activation of apoptosis in vivo.